<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Electron Physician</journal-id><journal-id journal-id-type="iso-abbrev">Electron Physician</journal-id><journal-id journal-id-type="publisher-id">Electronic physician</journal-id><journal-title-group><journal-title>Electronic Physician</journal-title></journal-title-group><issn pub-type="epub">2008-5842</issn><publisher><publisher-name>Electronic physician</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29403603</article-id><article-id pub-id-type="pmc">5783112</article-id><article-id pub-id-type="doi">10.19082/5670</article-id><article-id pub-id-type="publisher-id">epj-09-5670</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The effect of consumption of garlic tablet on proteins oxidation biomarkers in postmenopausal osteoporotic women: A randomized clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ahmadian</surname><given-names>Fereshte</given-names></name><xref ref-type="aff" rid="af1-epj-09-5670">1</xref></contrib><contrib contrib-type="author"><name><surname>Mozaffari-Khosravi</surname><given-names>Hassan</given-names></name><xref ref-type="aff" rid="af2-epj-09-5670">2</xref></contrib><contrib contrib-type="author"><name><surname>Azaraein</surname><given-names>Mohammad Hossein</given-names></name><xref ref-type="aff" rid="af3-epj-09-5670">3</xref></contrib><contrib contrib-type="author"><name><surname>Faraji</surname><given-names>Reza</given-names></name><xref ref-type="aff" rid="af4-epj-09-5670">4</xref></contrib><contrib contrib-type="author"><name><surname>Zavar-Reza</surname><given-names>Javad</given-names></name><xref ref-type="aff" rid="af5-epj-09-5670">5</xref><xref ref-type="corresp" rid="c1-epj-09-5670"/></contrib></contrib-group><aff id="af1-epj-09-5670">
<label>1</label>M.Sc., Department of Biochemistry, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</aff><aff id="af2-epj-09-5670">
<label>2</label>Ph.D., Department of Nutrition, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</aff><aff id="af3-epj-09-5670">
<label>3</label>M.Sc., Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</aff><aff id="af4-epj-09-5670">
<label>4</label>Ph.D., Kermanshah Cardiovascular Research Centre, Kermanshah University of Medical Sciences, Kermanshah, Iran</aff><aff id="af5-epj-09-5670">
<label>5</label>Ph.D., Department of Biochemistry, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</aff><author-notes><corresp id="c1-epj-09-5670">Corresponding author: Javad Zavar-Reza, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Tel: +98 9125028742, Fax: 0098 3535231421, Email: <email>jzavar@ssu.ac.ir</email></corresp></author-notes><pub-date pub-type="collection"><month>11</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>25</day><month>11</month><year>2017</year></pub-date><volume>9</volume><issue>11</issue><fpage>5670</fpage><lpage>5675</lpage><history><date date-type="received"><day>07</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>30</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 The Authors</copyright-statement><copyright-year>2017</copyright-year><license><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><sec><title>Background</title><p>Osteoporosis (OP) is one of the most prevalent metabolic bone diseases at higher ages, especially in postmenopausal women.</p></sec><sec><title>Objective</title><p>To determine the effect of consumption of garlic tablet on proteins oxidation biomarkers in postmenopausal osteoporotic women.</p></sec><sec><title>Methods</title><p>The present study was a double-blind randomized controlled clinical trial that included 42 postmenopausal women in Yazd during 2014&#x02013;2015. Osteoporotic women were randomly assigned into two groups: the garlic group (GG) and the placebo group (PG). Participants in GG took two garlic tablets daily for 1 month and the participants in PG took placebo tablets in the same manner. After 30 days, the plasma level of carbonyl groups (PCO), total antioxidant capacity (TAC), and advanced oxidation protein products (AOPPs) were assessed by spectrophotometric assays. Also, Malondialdehyde (MDA) content was measured according to the procedure of Thiobarbituric Acid (TBA). Data were analyzed by SPSS version 18, using paired-samples t-test, independent-samples t-test, Wilcoxon, and Mann-Whitney U test.</p></sec><sec><title>Results</title><p>This study showed that garlic tablets had decreased PCO plasma levels (47.37&#x000b1;5.98 vs. 19.62&#x000b1;3.40 nM, p&#x02264;0.001, before and after the study, respectively), AOPPs (738.95&#x000b1;151.86 vs. 585.12&#x000b1;209.99 &#x003bc;M, p&#x02264;0.008, before and after the study, respectively), and increased TAC (11.34&#x000b1;10.80 vs. 47.93&#x000b1;17.80, p&#x02264;0.001, before and after the study, respectively). The parameters in placebo groups showed no significant differences before and after the study, respectively. The levels of MDA before taking the drug in comparison to before Garlic group was also reduced (1.30&#x000b1;1.04 vs. 0.92&#x000b1;0.81 &#x003bc;M, p=0.01, before and after the study, respectively).</p></sec><sec><title>Conclusion</title><p>The role of oxidative stress in the pathophysiology of many diseases such as osteoporosis has been demonstrated. The present study showed that garlic consumption can reduce the oxidative stress.</p></sec><sec><title>Trial registration</title><p>The protocol of trial was registered at the Iranian clinical trial register (<ext-link ext-link-type="uri" xlink:href="www.irct.ir">www.irct.ir</ext-link>) with ID: IRCT138811183273N1.</p></sec><sec><title>Funding</title><p>This study funded by Shahid Sadoughi University of Medical Sciences (Yazd, Iran).</p></sec></abstract><kwd-group><kwd>Oxidative stress</kwd><kwd>Osteoporosis</kwd><kwd>Garlic tablets</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>Osteoporosis (OP) is a silent dangerous disease associated with lifestyle. OP causes fractures which can be mortal or disabling, and increases health care expenses (<xref rid="b1-epj-09-5670" ref-type="bibr">1</xref>). In 1991, the World Health Organization (WHO) announced OP as the fourth health-threatening factor after cancer, myocardial infarction and cerebrovascular disease (<xref rid="b2-epj-09-5670" ref-type="bibr">2</xref>). So, developing OP prevention strategies became one of the main goals of physicians, particularly nutritionists (<xref rid="b3-epj-09-5670" ref-type="bibr">3</xref>). It is estimated that about 61 million people will suffer from OP by the year 2020 (<xref rid="b4-epj-09-5670" ref-type="bibr">4</xref>). Without promotion in preventive strategies, its costs could rise to over 200 billion dollars by 2040 (<xref rid="b5-epj-09-5670" ref-type="bibr">5</xref>). Annually, about 1.5 million fractures occur in osteoporotic patients in the United States (<xref rid="b6-epj-09-5670" ref-type="bibr">6</xref>). OP begins in the fourth decade of life and is more common in women. One out of three females, one out of 12 males, half of the women older than 45 years, and 90% of 75+ year-old women develop OP (<xref rid="b7-epj-09-5670" ref-type="bibr">7</xref>). The main cause of the higher prevalence of this disorder in the female population is menopause and reduction in sexual steroid levels which lead to bone turnover and reduced bone density (<xref rid="b8-epj-09-5670" ref-type="bibr">8</xref>). Other underlying factors associated with OP are low mineral density like CA, protein and vitamin D deficiency, smoking, thyroid diseases, low level of sexual hormone, rheumatoid arthritis (RA), diabetes mellitus (DM), Cushing disease, Body index less than 10% than when at a younger age, body mass index (BMI) lower than 19, alcoholism, malnutrition and certain drugs (such as corticosteroids, furosemide, heparin and phenytoin (<xref rid="b9-epj-09-5670" ref-type="bibr">9</xref>). One of the biggest factors associated with OP is oxidative stress. Under normal conditions, the levels of free radicals such as reactive oxygen species (ROS) are maintained at low levels by and antioxidant systems (enzymes and chemical compounds) in biological systems. If an imbalance between free radicals and antioxidants, referred to as oxidative stress, occurs in the body (<xref rid="b10-epj-09-5670" ref-type="bibr">10</xref>), sex hormones (estrogens and androgens) can influence the growth and structure of the skeleton. So estrogen depletion at menopause in elderly women can cause the development of osteoporosis (<xref rid="b11-epj-09-5670" ref-type="bibr">11</xref>). There is some evidence showing the correlation between oxidative stress and loss of bone density (<xref rid="b12-epj-09-5670" ref-type="bibr">12</xref>). Some studies revealed that estrogen deprivation in menopause increases oxidative stress and bone loss (<xref rid="b13-epj-09-5670" ref-type="bibr">13</xref>). Sendur et al. confirmed the role of oxidative stress over bone density in OP with a study conducted on 45 women in the postmenopausal period (<xref rid="b14-epj-09-5670" ref-type="bibr">14</xref>). On the other hand, estrogen and other chemical therapies have their own complications and can increase the risk of some malignancies, so, extensive efforts have been made to find an effective treatment with the lowest side-effects. Herbal medicine proposed garlic as a treatment of bone loss process due to low estrogen level (<xref rid="b15-epj-09-5670" ref-type="bibr">15</xref>). Garlic is an antioxidant plant and its role in many diseases (like hyperlipidemia [HLP], DM, hypertension [HTN], malignancies) was proved in previous studies (<xref rid="b16-epj-09-5670" ref-type="bibr">16</xref>). Vazquez-Prieto et al. revealed its impact on reducing oxidative stress and vascular cell adhesion molecule-1imperssion in rats (<xref rid="b17-epj-09-5670" ref-type="bibr">17</xref>). A study confirmed that garlic extract antioxidant capacity can effectively decrease oxidative stress (<xref rid="b18-epj-09-5670" ref-type="bibr">18</xref>). As oxidative stress has an important role in OP and garlic has phytoestrogens and anti-oxidative effects, this study investigated the efficacy of garlic tablet in oxidative stress indexes in menopausal women with osteoporosis.</p></sec><sec><title>2. Material and Methods</title><p>This double-blinded study was conducted as a clinical trial on 42 menopausal women referred to the Milad Center for bone mass densitometry in Yazd during 2014&#x02013;2015. An informed written consent was received from each patient. They could freely leave the study at any time during the study. All patients were continuing their previous medical treatments and no interruptions were made. Research Ethics Committee of SSUMS approved research proposal of the study. The protocol of trial was registered at the Iranian clinical trial register (<ext-link ext-link-type="uri" xlink:href="www.irct.ir">www.irct.ir</ext-link>) with ID equal IRCT138811183273N1. Inclusion criteria included: proved OP (femoral or lumbar bone mass index lower than 2.5 g/cm<sup>2</sup>), and being aged between 45 and 65 years. Exclusion criteria included patients with heart diseases, HTN, HLP, gastric ulcer, drug use (aspirin, captopril and anticoagulants) a history of allergic reaction for garlic, and dermatitis. Informed written consent was obtained from all participants. Patients were randomly divided into case and control groups using random block method. In the case group, women received 2 garlic tablets daily with meals for one month and the control group received the same shaped tablet as placebo. Garlic tablets (Garlet) contained 1200 &#x003bc;g Alcin equal to 2 g fresh garlic and the placebo was obtained from Amin Industry, Esfahan, Iran. Before and after intervention, 5 cc of venous blood sample were obtained in non-fasting condition. Samples were frozen in -70&#x000b0; C. Plasma protein carbonyl (PCO), advanced oxidation protein products (AOPP), and total antioxidant capacity (TAC) (with 2, 2-diphenyl-1-picrylhydrazyl [DPPH] oxidation) were measured with the following methods: Walwadkar (<xref rid="b19-epj-09-5670" ref-type="bibr">19</xref>), Kataaha et al. (<xref rid="b20-epj-09-5670" ref-type="bibr">20</xref>), Girbal et al. (<xref rid="b21-epj-09-5670" ref-type="bibr">21</xref>), Kitajima (<xref rid="b22-epj-09-5670" ref-type="bibr">22</xref>) and Janaszewska et al. (<xref rid="b23-epj-09-5670" ref-type="bibr">23</xref>). Ikatsu (MDA) measurement was performed by thiobarbituric acid (TBA) (<xref rid="b24-epj-09-5670" ref-type="bibr">24</xref>). Data were coded and entered into SPSS version 18 (SPSS Inc., Chicago, Illinois, USA). Kolmogorov-Smirnov test was used to determine the cases normality. Inferential statistical analyses performed in this study were paired-samples t-test, independent-samples t-test, Wilcoxon, and Mann-Whitney U test. P-values less than 0.05 were considered significant. An informed written consent was received from each patient. They could freely leave the study. All patients were continuing their previous medical treatments and no interruptions were made. The Research Ethics Committee of SSUMS approved research proposal of the study.</p></sec><sec><title>3. Results</title><p>Forty-two women participating in this study were divided into two groups (<xref ref-type="fig" rid="f1-epj-09-5670">Figure 1</xref>). Demographic characteristics of patients are summarized in <xref ref-type="table" rid="t1-epj-09-5670">Table 1</xref>. As <xref ref-type="table" rid="t1-epj-09-5670">table 1</xref> showed at the beginning of the study, there was no significant difference between the averages of the baseline characteristics in two groups. Serum protein peroxidation measurements are shown in <xref ref-type="table" rid="t2-epj-09-5670">Table 2</xref>. Mean PCO level was significantly lower in the garlic group before and after intervention (p&#x0003c;0.001), and there was also a significant difference between the two groups (p&#x0003c;0.001). TAC mean level was lower before than after Garlet tablet administration (p&#x0003c;0.001). Also, the mean TAC level was significantly different between the two groups (p&#x0003c;0.001). AOPP level was higher before intervention (p=0.02) and this difference was significant between the groups (p=0.008). Moreover, MDA was reduced significantly after garlic treatment (p=0.01). However, no difference was observed in the control group (p=0.39).</p></sec><sec><title>4. Discussion</title><p>Osteoporosis is a bone metabolic disorder in women, particularly in post-menopausal ones. Chemical drugs administration and estrogen therapy have their own side-effects. The traditional medicine and new advantages in herbal drugs reveal the role of medicinal herbs on oxidative stress reduction; onion, ginger, Nigella sativa, Berberis vulgaris extract. In this study, we showed the beneficial effect of garlic tablet on lipid and protein oxidation markers in post-menopausal osteoporosis. The beneficial effects of garlic against oxidative stress are numerous: Garlic decreases NADPH oxidase activity and VCAM-1 expression and therefore decreases inflammation.. Inflammation has a strong association with oxidative stress (<xref rid="b17-epj-09-5670" ref-type="bibr">17</xref>). The S-allyl cysteine (DAS) and s-allyl methyl cysteine (DADS) are the main components of garlic that have high antioxidant properties. DADS can protect osteoblasts from reactive oxygen species (ROS) formation. DADS can protect osteoblasts from reactive oxygen species (ROS) formation in smokers (<xref rid="b22-epj-09-5670" ref-type="bibr">22</xref>). Also, according to the past studies, these results could be due to allicin (inhibits down regulation of the c-Jun N-terminal Kinase Signaling Pathway and so, cell adhesion molecules expression), the protective role of S-allyl cysteine, in oxidized-LDL formation and inhibition of activation of nuclear factor kappa B activated by or hydrogen peroxide. However, some recent studies have been mentioned the anti-inflammatory effect of quercetin (another flavonoid in onion with antioxidant activity) (<xref rid="b25-epj-09-5670" ref-type="bibr">25</xref>&#x02013;<xref rid="b27-epj-09-5670" ref-type="bibr">27</xref>). Quercetin can attenuate the TNF-alpha and NO production (<xref rid="b28-epj-09-5670" ref-type="bibr">28</xref>). Garlic extract has the anti-hypertrophic and anti-apoptotic role on the myocardial cell (<xref rid="b29-epj-09-5670" ref-type="bibr">29</xref>). As in some recent studies, our study confirmed that garlic tablet can prevent PCO incidence in menopausal women (<xref rid="b30-epj-09-5670" ref-type="bibr">30</xref>). Lai et al. showed that DADS of garlic can prevent problems associated with fatty liver by inhibiting oxidative stress in obese mice (<xref rid="b32-epj-09-5670" ref-type="bibr">32</xref>). Our findings revealed that garlic tablet reduced AOPPs levels in patients. Avci et al. proposed the efficacy of garlic in reducing AOPPs, osteoporosis, and oxidative stress in 66 rats exposed to mobile radio frequency waves (33). The animal study by Sun et al. on rats, showed that AOPPs can prevent bone stem cells proliferation and differentiation, and it might be important in osteoporosis process (34). Zeng et al. proposed that AOPPs accumulation in old mice, increases bone destruction most probably by activation of NADPH oxidase, and also by inhibition of bone reabsorption which has a great role in osteoporosis development (35). In this study, free radical-trapping capacity was statistically different between groups and there was a significant difference before and after garlic tablet administration. Muhammad et al. evaluated oxidative stress in rats after ovariectomy and observed that ovariectomy leads to osteoclasts and osteoblasts proliferation, and bone regulation antioxidant administration such as vitamin E can increase osteoblasts, so improve bone density indices (36). Leain et al., in their study showed that ROS has a negative correlation with estrogen and increases in rats and mice after ovariectomy which activates osteoclasts and suppresses osteoblasts (37). The study by Ehnert et al. assessed cell culture of osteoblasts derived from the femoral bone head of smokers and showed that garlic oil can prevent oxidative stress and promote their activity. They found that DADS was more effective compared to DAS in ROS reduction (38). Mukherjee et al. showed that garlic oil can reduce oxidative stress in lymphocytes and macrophages by estrogen levels compliance in rats and also antioxidant and interleukins increase can protect bone density. They suggested that garlic has a preventive role in bone mass reduction (39). Our study confirmed that MDA (results from the oxidative breakdown of polyunsaturated fatty acids) was reduced significantly after garlic administration. Free radicals&#x02019; formation occurs in physiologic and pathologic conditions in mammal tissue (40), which react with polyunsaturated fatty acids and produce lipid peroxidation. Fatty oxidation reaction requires the attack to free bases of polyunsaturated fatty acids. Lipid damage occurs after double bond allelic base formation. Weak double bonds can combine with oxygen and produce lipid peroxide base, while lipid peroxide decomposes to aldehyde (like MDA). This component can attach to cellular lipid, protein or Deoxyribonucleic acid (DNA) and lead to structural change (41). Avci et al. showed that garlic can reduce MDA in plasma, red blood cells, and this herb also decreases oxidation reaction and increases antioxidant enzymes (33). Garlic neutralizes the effect of estrogen reduction with calcium absorption. Some reports showed anti-osteoporotic effects of garlic by the preventive role of biomarkers of estrogen deficiency and bone mass decrease and also serum alkaline phosphatase levels (<xref rid="b7-epj-09-5670" ref-type="bibr">7</xref>, <xref rid="b8-epj-09-5670" ref-type="bibr">8</xref>).</p></sec><sec><title>5. Conclusions</title><p>Regarding the findings our study and previous ones, it can be concluded that garlic-derived medicine or raw garlic can be used in osteoporosis to perform calcium absorption. It also might have a great impact on carbonyl groups, AOPPs, and ROS. Garlic influences osteoporosis by oxidative stress reduction. In our study, increased oxidative stress index such as free radicals was observed in the garlic-treated group but it was reduced in the carbonyl group and AOPPs significantly after garlic administration. MDA also decreased significantly after tablet usage.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to express their thanks to the Board of Directors of Shahid Sadoughi University of Medical Sciences.</p></ack><fn-group><fn id="fn1-epj-09-5670"><p>iThenticate screening: August 31, 2017, English editing: October 07, 2017, Quality control: October 15, 2017</p></fn><fn id="fn2-epj-09-5670"><p><bold>Trial registration:</bold></p><p>The protocol of trial was registered at the Iranian clinical trial register (<ext-link ext-link-type="uri" xlink:href="www.irct.ir">www.irct.ir</ext-link>) with ID: IRCT138811183273N1.</p></fn><fn id="fn3-epj-09-5670"><p><bold>Funding:</bold></p><p>This study funded by Shahid Sadoughi University of Medical Sciences (Yazd, Iran).</p></fn><fn id="fn4-epj-09-5670" fn-type="COI-statement"><p><bold>Conflict of Interest:</bold></p><p>There is no conflict of interest to be declared.</p></fn><fn id="fn5-epj-09-5670"><p><bold>Authors&#x02019; contributions:</bold></p><p>All authors contributed to this project and article equally. All authors read and approved the final manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-epj-09-5670"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahbazian</surname><given-names>H</given-names></name></person-group><article-title>World diabetes day; 2013</article-title><source>J Renal Inj Prev</source><year>2013</year><volume>2</volume><issue>4</issue><fpage>123</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.12861/jrip.2013.39</pub-id><pub-id pub-id-type="pmid">25340148</pub-id></element-citation></ref><ref id="b2-epj-09-5670"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elalamy</surname><given-names>I</given-names></name><name><surname>Chakroun</surname><given-names>T</given-names></name><name><surname>Gerotziafas</surname><given-names>GT</given-names></name><name><surname>Petropoulou</surname><given-names>A</given-names></name><name><surname>Robert</surname><given-names>F</given-names></name><name><surname>Karroum</surname><given-names>A</given-names></name><etal/></person-group><article-title>Circulating platelet leukocyte aggregates: a marker of microvascular injury in diabetic patients</article-title><source>Thromb Res</source><year>2008</year><volume>121</volume><issue>6</issue><fpage>843</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.thromres.2007.07.016</pub-id><pub-id pub-id-type="pmid">17825880</pub-id></element-citation></ref><ref id="b3-epj-09-5670"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jindal</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Kakkar</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>HV</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><etal/></person-group><article-title>Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications</article-title><source>Hematology</source><year>2011</year><volume>16</volume><issue>2</issue><fpage>86</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1179/102453311X12902908412110</pub-id><pub-id pub-id-type="pmid">21418738</pub-id></element-citation></ref><ref id="b4-epj-09-5670"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demirtas</surname><given-names>L</given-names></name><name><surname>Degirmenci</surname><given-names>H</given-names></name><name><surname>Akbas</surname><given-names>EM</given-names></name><name><surname>Ozcicek</surname><given-names>A</given-names></name><name><surname>Timuroglu</surname><given-names>A</given-names></name><name><surname>Gurel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Association of hematological indices with diabetes, impaired glucose regulation and microvascular complications of diabetes</article-title><source>Int J Clin Exp Med</source><year>2015</year><volume>8</volume><issue>7</issue><fpage>11420</fpage><lpage>5</lpage><!--<pub-id pub-id-type="pmcid">PMC4565341</pub-id>--><pub-id pub-id-type="pmid">26379958</pub-id></element-citation></ref><ref id="b5-epj-09-5670"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Muller</surname><given-names>DC</given-names></name><name><surname>Nathan</surname><given-names>DM</given-names></name><name><surname>Blake</surname><given-names>DR</given-names></name><name><surname>Andres</surname><given-names>R</given-names></name></person-group><article-title>The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore longitudinal study of aging</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><issue>6</issue><fpage>1475</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.2337/diabetes.52.6.1475</pub-id><pub-id pub-id-type="pmid">12765960</pub-id></element-citation></ref><ref id="b6-epj-09-5670"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levitzky</surname><given-names>YS</given-names></name><name><surname>Pencina</surname><given-names>MJ</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>RB</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Murabito</surname><given-names>JM</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Impact of Impaired Fasting Glucose on Cardiovascular Disease</article-title><source>J Am Coll Cardiol</source><year>2008</year><volume>51</volume><issue>3</issue><fpage>264</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2007.09.038</pub-id><pub-id pub-id-type="pmid">18206734</pub-id></element-citation></ref><ref id="b7-epj-09-5670"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YI</given-names></name><name><surname>Mooney</surname><given-names>MP</given-names></name><name><surname>Cho</surname><given-names>DJ</given-names></name></person-group><article-title>Hemorheological disorders in diabetes mellitus</article-title><source>J Diabetes Sci Technol</source><year>2008</year><volume>2</volume><issue>6</issue><fpage>1130</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1177/193229680800200622</pub-id><!--<pub-id pub-id-type="pmcid">PMC2769810</pub-id>--><pub-id pub-id-type="pmid">19885302</pub-id></element-citation></ref><ref id="b8-epj-09-5670"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamariz</surname><given-names>LJ</given-names></name><name><surname>Young</surname><given-names>JH</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Yeh</surname><given-names>HC</given-names></name><name><surname>Schmidt</surname><given-names>MI</given-names></name><name><surname>Astor</surname><given-names>B</given-names></name><etal/></person-group><article-title>Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study</article-title><source>Am J Epidemiol</source><year>2008</year><volume>168</volume><fpage>1153</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1093/aje/kwn243</pub-id><!--<pub-id pub-id-type="pmcid">PMC2581671</pub-id>--><pub-id pub-id-type="pmid">18931370</pub-id></element-citation></ref><ref id="b9-epj-09-5670"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biadgo</surname><given-names>B</given-names></name><name><surname>Melku</surname><given-names>M</given-names></name><name><surname>Abebe</surname><given-names>SM</given-names></name><name><surname>Abebe</surname><given-names>M</given-names></name></person-group><article-title>Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia</article-title><source>Diabetes Metab Syndr Obes</source><year>2016</year><volume>9</volume><fpage>91</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.2147/DMSO.S97563</pub-id><!--<pub-id pub-id-type="pmcid">PMC4801204</pub-id>--><pub-id pub-id-type="pmid">27042134</pub-id></element-citation></ref><ref id="b10-epj-09-5670"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>LK</given-names></name><name><surname>Ming-Hsien</surname><given-names>L</given-names></name><name><surname>Zhi-Jun</surname><given-names>C</given-names></name><name><surname>Shinn-Jang</surname><given-names>H</given-names></name><name><surname>Chiou</surname><given-names>ST</given-names></name></person-group><article-title>Association of insulin resistance and hematologic parameters: study of a middle-aged and elderly Chinese population in Taiwan</article-title><source>J Chin Med Assoc</source><year>2006</year><volume>69</volume><issue>6</issue><fpage>248</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/S1726-4901(09)70251-5</pub-id><pub-id pub-id-type="pmid">16863009</pub-id></element-citation></ref><ref id="b11-epj-09-5670"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>D</given-names></name></person-group><article-title>Increased red cell count in diabetes and pre-diabetes</article-title><source>Diabetes Res Clin Pract</source><year>2010</year><volume>90</volume><issue>3</issue><fpage>e50</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2010.07.005</pub-id><pub-id pub-id-type="pmid">20701991</pub-id></element-citation></ref><ref id="b12-epj-09-5670"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gokulakrishnan</surname><given-names>K</given-names></name><name><surname>Deepa</surname><given-names>R</given-names></name><name><surname>Sampathkumar</surname><given-names>R</given-names></name><name><surname>Balasubramanyam</surname><given-names>M</given-names></name><name><surname>Mohan</surname><given-names>V</given-names></name></person-group><article-title>Association of leukocyte count with varying degrees of glucose intolerance in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-26)</article-title><source>Metab Syndr Relat Disord</source><year>2009</year><volume>7</volume><issue>3</issue><fpage>205</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1089/met.2008.0024</pub-id><pub-id pub-id-type="pmid">19284318</pub-id></element-citation></ref><ref id="b13-epj-09-5670"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coban</surname><given-names>E</given-names></name><name><surname>Kucuktag</surname><given-names>S</given-names></name><name><surname>Basyigit</surname><given-names>S</given-names></name></person-group><article-title>Platelet activation in subjects with impaired glucose tolerance</article-title><source>Platelets</source><year>2007</year><volume>18</volume><fpage>591</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1080/09537100701609019</pub-id><pub-id pub-id-type="pmid">18041650</pub-id></element-citation></ref><ref id="b14-epj-09-5670"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anuurad</surname><given-names>E</given-names></name><name><surname>Shiwaku</surname><given-names>K</given-names></name><name><surname>Nogi</surname><given-names>A</given-names></name><name><surname>Kitajima</surname><given-names>K</given-names></name><name><surname>Enkhmaa</surname><given-names>B</given-names></name><name><surname>Shimono</surname><given-names>K</given-names></name><etal/></person-group><article-title>The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers</article-title><source>J Occup Health</source><year>2003</year><volume>45</volume><issue>6</issue><fpage>335</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1539/joh.45.335</pub-id><pub-id pub-id-type="pmid">14676412</pub-id></element-citation></ref><ref id="b15-epj-09-5670"><label>15</label><element-citation publication-type="journal"><collab>American Diabetes Association</collab><article-title>Diagnosis and Classification of Diabetes Mellitus</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><issue>Suppl 1</issue><fpage>S62</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.2337/dc10-S062</pub-id><!--<pub-id pub-id-type="pmcid">PMC2797383</pub-id>--><pub-id pub-id-type="pmid">20042775</pub-id></element-citation></ref><ref id="b16-epj-09-5670"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>BT</given-names></name><name><surname>Nava</surname><given-names>AJ</given-names></name><name><surname>George</surname><given-names>TI</given-names></name></person-group><article-title>Evaluation of the Beckman Coulter UniCel DxH 800, Beckman Coulter LH 780, and Abbott Diagnostics Cell-Dyn Sapphire hematology analyzers on adult specimens in a tertiary care hospital</article-title><source>Am J Clin Pathol</source><year>2011</year><volume>135</volume><fpage>939</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1309/AJCP1V3UXEIQTSLE</pub-id><pub-id pub-id-type="pmid">21571967</pub-id></element-citation></ref><ref id="b17-epj-09-5670"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezenwaka</surname><given-names>CE</given-names></name><name><surname>Jones-Lecointe</surname><given-names>A</given-names></name><name><surname>Nwagbara</surname><given-names>E</given-names></name><name><surname>Seales</surname><given-names>D</given-names></name><name><surname>Okali</surname><given-names>F</given-names></name></person-group><article-title>Anemia and kidney dysfunction in Caribbean type 2 diabetic patients</article-title><source>Cardiovasc Diabetol</source><year>2008</year><volume>7</volume><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/1475-2840-7-25</pub-id><pub-id pub-id-type="pmid">18752687</pub-id></element-citation></ref><ref id="b18-epj-09-5670"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meisinger</surname><given-names>C</given-names></name><name><surname>R&#x000fc;ckert</surname><given-names>IM</given-names></name><name><surname>St&#x000f6;ckl</surname><given-names>D</given-names></name><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Kowall</surname><given-names>B</given-names></name><etal/></person-group><article-title>Hematological Parameters and Prediabetes and Diabetes in Adults from the General Population: A Cross-Sectional Study</article-title><source>J Diabetes Metab</source><year>2014</year><volume>5</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.4172/2155-6156.1000335</pub-id></element-citation></ref><ref id="b19-epj-09-5670"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Mao</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>U-shape association between white blood cell count and the risk of diabetes in young Chinese adults</article-title><source>Diabet Med</source><year>2009</year><volume>26</volume><issue>10</issue><fpage>955</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2009.02801.x</pub-id><pub-id pub-id-type="pmid">19900225</pub-id></element-citation></ref><ref id="b20-epj-09-5670"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>S</given-names></name><name><surname>Kerman</surname><given-names>SR</given-names></name><name><surname>Rohani</surname><given-names>F</given-names></name><name><surname>Salari</surname><given-names>F</given-names></name></person-group><article-title>Association between diabetes complications and leukocyte counts in Iranian patients</article-title><source>J Inflamm Res</source><year>2012</year><volume>5</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.2147/JIR.S26917</pub-id><!--<pub-id pub-id-type="pmcid">PMC3278259</pub-id>--><pub-id pub-id-type="pmid">22334791</pub-id></element-citation></ref><ref id="b21-epj-09-5670"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>PC</given-names></name><name><surname>Lee</surname><given-names>KF</given-names></name><name><surname>So</surname><given-names>WY</given-names></name><name><surname>Ng</surname><given-names>MH</given-names></name><name><surname>Chan</surname><given-names>WB</given-names></name><name><surname>Lo</surname><given-names>MK</given-names></name><etal/></person-group><article-title>White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><issue>1</issue><fpage>216</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.2337/diacare.27.1.216</pub-id><pub-id pub-id-type="pmid">14693992</pub-id></element-citation></ref><ref id="b22-epj-09-5670"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Ju</surname><given-names>L</given-names></name><name><surname>Tong</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: longitudinal study</article-title><source>Hypertension</source><year>2015</year><volume>65</volume><issue>3</issue><fpage>525</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.114.04632</pub-id><pub-id pub-id-type="pmid">25624343</pub-id></element-citation></ref><ref id="b23-epj-09-5670"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kang</surname><given-names>ES</given-names></name><name><surname>Ahn</surname><given-names>CW</given-names></name><name><surname>Lim</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>HC</given-names></name><etal/></person-group><article-title>The association of total and differential white blood cell count with metabolic syndrome in type 2diabetic patients</article-title><source>Diabetes Res Clin Pract</source><year>2006</year><volume>73</volume><issue>3</issue><fpage>284</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2006.02.001</pub-id><pub-id pub-id-type="pmid">16563549</pub-id></element-citation></ref><ref id="b24-epj-09-5670"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>FM</given-names></name><name><surname>Tsai</surname><given-names>JC</given-names></name><name><surname>Chang</surname><given-names>DM</given-names></name><name><surname>Shin</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name></person-group><article-title>Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis</article-title><source>Diabetes Care</source><year>2005</year><volume>28</volume><issue>7</issue><fpage>1710</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.2337/diacare.28.7.1710</pub-id><pub-id pub-id-type="pmid">15983324</pub-id></element-citation></ref><ref id="b25-epj-09-5670"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dada</surname><given-names>OA</given-names></name><name><surname>Uche</surname><given-names>E</given-names></name><name><surname>Akinbami</surname><given-names>A</given-names></name><name><surname>Odesanya</surname><given-names>M</given-names></name><name><surname>John-Olabode</surname><given-names>S</given-names></name><name><surname>Adediran</surname><given-names>A</given-names></name><etal/></person-group><article-title>The relationship between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in Lagos, Nigeria</article-title><source>J Blood Med</source><year>2014</year><volume>5</volume><fpage>185</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.2147/JBM.S67989</pub-id><pub-id pub-id-type="pmid">25278786</pub-id></element-citation></ref><ref id="b26-epj-09-5670"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malandrino</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>WC</given-names></name><name><surname>Taveira</surname><given-names>TH</given-names></name><name><surname>Whitlatch</surname><given-names>HB</given-names></name><name><surname>Smith</surname><given-names>RJ</given-names></name></person-group><article-title>Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes</article-title><source>Diabetologia</source><year>2012</year><volume>55</volume><issue>1</issue><fpage>226</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s00125-011-2331-1</pub-id><pub-id pub-id-type="pmid">22002006</pub-id></element-citation></ref><ref id="b27-epj-09-5670"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesfamariam</surname><given-names>B</given-names></name><name><surname>Cohen</surname><given-names>RA</given-names></name></person-group><article-title>Free radicals mediate endothelial cell dysfunction caused by elevated glucose</article-title><source>Am J Physiol</source><year>1992</year><volume>263</volume><issue>2 Pt 2</issue><fpage>H321</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1510128</pub-id></element-citation></ref><ref id="b28-epj-09-5670"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>GL</given-names></name><name><surname>Loeken</surname><given-names>MR</given-names></name></person-group><article-title>Hyperglycemia-induced oxidative stress in diabetic complications</article-title><source>Histochem Cell Biol</source><year>2004</year><volume>122</volume><issue>4</issue><fpage>333</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s00418-004-0678-9</pub-id><pub-id pub-id-type="pmid">15257460</pub-id></element-citation></ref><ref id="b29-epj-09-5670"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerner</surname><given-names>RR</given-names></name><name><surname>Wieser</surname><given-names>V</given-names></name><name><surname>Moschen</surname><given-names>AR</given-names></name><name><surname>Tilg</surname><given-names>H</given-names></name></person-group><article-title>Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liver</article-title><source>Can J Physiol Pharmacol</source><year>2013</year><volume>91</volume><issue>11</issue><fpage>867</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1139/cjpp-2013-0050</pub-id><pub-id pub-id-type="pmid">24117253</pub-id></element-citation></ref><ref id="b30-epj-09-5670"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cawood</surname><given-names>TJ</given-names></name><name><surname>Buckley</surname><given-names>U</given-names></name><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>Corbett</surname><given-names>M</given-names></name><name><surname>Dillon</surname><given-names>D</given-names></name><name><surname>Goodwin</surname><given-names>B</given-names></name><etal/></person-group><article-title>Prevalence of anaemia in patients with diabetes mellitus</article-title><source>Ir J Med Sci</source><year>2006</year><volume>175</volume><issue>2</issue><fpage>25</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/BF03167944</pub-id><pub-id pub-id-type="pmid">16872024</pub-id></element-citation></ref><ref id="b31-epj-09-5670"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZS</given-names></name><name><surname>Song</surname><given-names>ZC</given-names></name><name><surname>Bai</surname><given-names>JH</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><etal/></person-group><article-title>Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus</article-title><source>Vasc Health Risk Manag</source><year>2013</year><volume>9</volume><fpage>237</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.2147/VHRM.S43211</pub-id><!--<pub-id pub-id-type="pmcid">PMC3656917</pub-id>--><pub-id pub-id-type="pmid">23690689</pub-id></element-citation></ref><ref id="b32-epj-09-5670"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>PE</given-names></name></person-group><article-title>Anaemia, diabetes and chronic kidney disease: where are we now?</article-title><source>J Ren Care</source><year>2012</year><volume>38</volume><issue> Suppl 1</issue><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1111/j.1755-6686.2012.00281.x</pub-id><pub-id pub-id-type="pmid">22348366</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-epj-09-5670" position="float"><label>Figure 1</label><caption><p>Flowchart of study design and sampling scheme</p></caption><graphic xlink:href="EPJ-09-5670-g001"/></fig><table-wrap id="t1-epj-09-5670" position="float"><label>Table 1</label><caption><p>Baseline characteristics of groups under study</p></caption><table frame="box" rules="all"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Characteristics</th><th valign="bottom" align="left" rowspan="1" colspan="1">Garlic group (Mean&#x000b1;SD)</th><th valign="bottom" align="left" rowspan="1" colspan="1">Placebo group (Mean&#x000b1;SD)</th><th valign="bottom" align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (year)</td><td valign="top" align="left" rowspan="1" colspan="1">56.10&#x000b1;5.81</td><td valign="top" align="left" rowspan="1" colspan="1">57.27&#x000b1;5.84</td><td valign="top" align="left" rowspan="1" colspan="1">0.51</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age of menarche (year)</td><td valign="top" align="left" rowspan="1" colspan="1">13.55&#x000b1;0.95</td><td valign="top" align="left" rowspan="1" colspan="1">13.68&#x000b1;1.39</td><td valign="top" align="left" rowspan="1" colspan="1">0.72</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age of menopause (year)</td><td valign="top" align="left" rowspan="1" colspan="1">48.55&#x000b1;4.40</td><td valign="top" align="left" rowspan="1" colspan="1">48.22&#x000b1;5.38</td><td valign="top" align="left" rowspan="1" colspan="1">0.83</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td valign="top" align="left" rowspan="1" colspan="1">27.27&#x000b1;2.58</td><td valign="top" align="left" rowspan="1" colspan="1">27.59&#x000b1;2.93</td><td valign="top" align="left" rowspan="1" colspan="1">0.51</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMD in lumbar spine (g/cm<sup>2</sup>)</td><td valign="top" align="left" rowspan="1" colspan="1">3.28&#x000b1;0.60</td><td valign="top" align="left" rowspan="1" colspan="1">3.28&#x000b1;0.83</td><td valign="top" align="left" rowspan="1" colspan="1">0.98</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMD in neck femur (g/cm<sup>2</sup>)</td><td valign="top" align="left" rowspan="1" colspan="1">1.91&#x000b1;0.90</td><td valign="top" align="left" rowspan="1" colspan="1">3.28&#x000b1;0.82</td><td valign="top" align="left" rowspan="1" colspan="1">0.91</td></tr></tbody></table></table-wrap><table-wrap id="t2-epj-09-5670" position="float"><label>Table 2</label><caption><p>Comparison of oxidation proteins and lipids products before and after intervention in garlic group and placebo group</p></caption><table frame="box" rules="all"><thead><tr><th colspan="2" valign="bottom" align="left" rowspan="1">Variables</th><th valign="bottom" align="left" rowspan="1" colspan="1">Garlic group (Mean&#x000b1;SD)</th><th valign="bottom" align="left" rowspan="1" colspan="1">Placebo group (Mean&#x000b1;SD)</th><th valign="bottom" align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td rowspan="3" valign="top" align="left" colspan="1">PCO (nM)</td><td valign="top" align="left" rowspan="1" colspan="1">Before</td><td valign="top" align="left" rowspan="1" colspan="1">47.37&#x000b1;5.98</td><td valign="top" align="left" rowspan="1" colspan="1">43.61&#x000b1;7.35</td><td valign="top" align="left" rowspan="1" colspan="1">0.079</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After</td><td valign="top" align="left" rowspan="1" colspan="1">19.62&#x000b1;3.40</td><td valign="top" align="left" rowspan="1" colspan="1">42.48&#x000b1;11.58</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">p-value</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.92</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="3" valign="top" align="left" colspan="1">TAC (% DPPH Reduction)</td><td valign="top" align="left" rowspan="1" colspan="1">Before</td><td valign="top" align="left" rowspan="1" colspan="1">11.34&#x000b1;10.80</td><td valign="top" align="left" rowspan="1" colspan="1">11.69&#x000b1;7.77</td><td valign="top" align="left" rowspan="1" colspan="1">0.07</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After</td><td valign="top" align="left" rowspan="1" colspan="1">47.93&#x000b1;17.80</td><td valign="top" align="left" rowspan="1" colspan="1">16.64&#x000b1;8.15</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">p-value</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.92</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="3" valign="top" align="left" colspan="1">AOPP (&#x003bc;m)</td><td valign="top" align="left" rowspan="1" colspan="1">Before</td><td valign="top" align="left" rowspan="1" colspan="1">738.95&#x000b1;151.86</td><td valign="top" align="left" rowspan="1" colspan="1">736.50&#x000b1;95.69</td><td valign="top" align="left" rowspan="1" colspan="1">0.08</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After</td><td valign="top" align="left" rowspan="1" colspan="1">585.12&#x000b1;209.99</td><td valign="top" align="left" rowspan="1" colspan="1">666.03&#x000b1;208.22</td><td valign="top" align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">p-value</td><td valign="top" align="left" rowspan="1" colspan="1">0.008</td><td valign="top" align="left" rowspan="1" colspan="1">0.16</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="3" valign="top" align="left" colspan="1">MDA (&#x003bc;m)</td><td valign="top" align="left" rowspan="1" colspan="1">Before</td><td valign="top" align="left" rowspan="1" colspan="1">1.30&#x000b1;1.04</td><td valign="top" align="left" rowspan="1" colspan="1">1.28&#x000b1;1.08</td><td valign="top" align="left" rowspan="1" colspan="1">0.72</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After</td><td valign="top" align="left" rowspan="1" colspan="1">0.92&#x000b1;0.81</td><td valign="top" align="left" rowspan="1" colspan="1">1.54&#x000b1;1.50</td><td valign="top" align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">p-value</td><td valign="top" align="left" rowspan="1" colspan="1">0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.39</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></floats-group></article>